9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/27/25 08:13
3/26/25
VNRXVolitionrx LtdDEHealthDiagnIn Vitro & In Vivo DiagnosticReynolds Cameron JohnNVDOP,CEO1P1000.5500018263,341D
3/27/25 08:13
3/26/25
VNRXVolitionrx LtdDEHealthDiagnIn Vitro & In Vivo DiagnosticInnes Guy ArchibaldNVD1P1000.5500018263,243D
3/19/25 16:38
3/17/25
ACHVAchieve Life Sciences, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticOki Mark KWAOCFO1P292.8901010D
3/19/25 16:32
3/17/25
ACHVAchieve Life Sciences, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticStewart Richard AlistairWADOChieve E1P292.860101962D
2/11/25 19:00
2/7/25
OCXOncocyte CorpCAHealthDiagnIn Vitro & In Vivo DiagnosticJames Andrea S.CAOCFO1P2002.05098182151D
2/11/25 17:00
2/7/25
OCXOncocyte CorpCAHealthDiagnIn Vitro & In Vivo DiagnosticSmith Patrick WCAT4P.m2,2532.0501,099513,258I
2/10/25 20:43
2/6/25
OCXOncocyte CorpCAHealthDiagnIn Vitro & In Vivo DiagnosticBroadwood Partners, L.P.NYT1P.d10,5902.0505,1662922,820M
1/16/25 15:28
1/16/25
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticNaemura David H.MIOCFO1P16411.110153261D
1/16/25 12:05
1/16/25
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticAdent John EdwardMIOCEO1P25411.030239269D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact